Dalian BIO-CHEM Company Limited (SHA:603360)

Dalian BIO-CHEM Company Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	651.63	668.24	539.52	417.96	293.88	333.07
Trading Asset Securities	100	-	60.01	-	0.63	10.34
Cash & Short-Term Investments	751.63	668.24	599.54	417.96	294.51	343.4
Cash Growth	79.74%	11.46%	43.44%	41.92%	-14.24%	41.83%
Accounts Receivable	289.54	419.13	168.24	176.6	192.87	134.2
Other Receivables	137.04	132.45	222.09	224.56	1.09	1.22
Receivables	426.57	551.58	390.32	401.16	193.97	135.42
Inventory	1,148	902.35	206.94	181.04	186.73	106.11
Other Current Assets	82.01	390.85	70.64	50.32	52.56	26.58
Total Current Assets	2,408	2,513	1,267	1,050	727.77	611.52
Property, Plant & Equipment	673.88	696.43	619.51	630.4	825.83	542.56
Long-Term Investments	149.69	-	7.02	13.89	-	132.31
Goodwill	230.53	230.53	-	-	-	-
Other Intangible Assets	127.73	137.21	42.17	43.18	92.16	93.36
Long-Term Deferred Tax Assets	27.48	28.41	-	11.2	17.82	11.62
Long-Term Deferred Charges	28.43	25.74	-	-	0.55	0.93
Other Long-Term Assets	10.08	8.42	5.58	5.24	6.59	37.39
Total Assets	3,656	3,640	1,942	1,754	1,671	1,430
Accounts Payable	94.61	117.72	62.64	66.77	142.02	65.37
Accrued Expenses	16.09	30.62	16.09	17.86	14.26	12.55
Short-Term Debt	282.24	423.94	150.01	129.11	338.5	300
Current Portion of Long-Term Debt	128.73	29	-	-	-	-
Current Portion of Leases	-	6.49	0.4	-	-	-
Current Income Taxes Payable	27.86	45.86	13.93	-	0.16	14.24
Current Unearned Revenue	199.88	347.91	2.35	2.15	4.37	3.44
Other Current Liabilities	62.77	110.98	24.38	24.96	37.56	0.44
Total Current Liabilities	812.17	1,113	269.8	240.86	536.89	396.05
Long-Term Debt	683.86	86	-	-	-	-
Long-Term Leases	24.82	22.6	0.38	-	-	-
Long-Term Unearned Revenue	12.43	8.06	9.34	10.63	37.32	41.09
Long-Term Deferred Tax Liabilities	37.22	52.9	25.46	41.63	36.85	4.27
Other Long-Term Liabilities	6.95	6.49	-	-	10	-
Total Liabilities	1,577	1,289	304.99	293.12	621.07	441.41
Common Stock	706.22	504.45	360.32	258.95	261.35	261.35
Additional Paid-In Capital	102.1	97.03	78.96	129.71	139.68	194.98
Retained Earnings	819.13	1,199	1,214	1,190	787.04	686.69
Treasury Stock	-111.57	-	-10.53	-117.72	-138.56	-154.89
Comprehensive Income & Other	-9.64	-11.58	-5.67	0.66	0.15	0.16
Total Common Equity	1,506	1,788	1,637	1,461	1,050	988.28
Minority Interest	572.06	562.72	-	-	-	-
Shareholders' Equity	2,078	2,351	1,637	1,461	1,050	988.28
Total Liabilities & Equity	3,656	3,640	1,942	1,754	1,671	1,430
Total Debt	1,120	568.03	150.79	129.11	338.5	300
Net Cash (Debt)	-368.02	100.21	448.74	288.85	-44	43.4
Net Cash Growth	-	-77.67%	55.36%	-	-	-79.53%
Net Cash Per Share	-0.52	0.14	0.64	0.42	-0.06	0.06
Filing Date Shares Outstanding	700.86	706.22	701.37	696.35	701.64	694.88
Total Common Shares Outstanding	700.86	706.22	701.37	696.35	701.64	694.88
Working Capital	1,596	1,401	997.63	809.62	190.88	215.47
Book Value Per Share	2.15	2.53	2.33	2.10	1.50	1.42
Tangible Book Value	1,148	1,421	1,595	1,418	957.5	894.92
Tangible Book Value Per Share	1.64	2.01	2.27	2.04	1.36	1.29
Buildings	-	356	352.23	329.53	413.34	264.73
Machinery	-	654.38	569.13	547.95	575.64	314.66
Construction In Progress	-	25.39	1.21	0.22	88.14	181.14

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.